| Market Cap | ₹1,442Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 44.53 |
| EPS(TTM) | 6.22 |
| P/B Ratio | 6.26 |
| Dividend Yield | 0.00% |
| Industry P/E | 58.28 |
| Book Value | 44.24 |
| Debt to Equity | 0.51 |
| Face Value | 2 |
| Managing Director | Somnath Chatterjee |
| Founded | 2005 |
| NSE Symbol | SURAKSHA |
| FUND NAME | AUM(%) |
|---|---|
| Nippon India Pharma Fund Direct Growth | 1.32% |
| JM Value Fund Direct Plan Growth | 0.72% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 44.20 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 63.39 | ||
| Metropolis Healthcare | NA (0.00%) | 57.85 | ||
| Thyrocare Technologies | NA (0.00%) | 46.76 |